Neurocrine Biosciences, Inc. (NASDAQ: NBIX) and BIAL today announced that they have entered into an exclusive licensing agreement for the development and commercialization of opicapone in North America.
Category: Healthcare
Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
Botox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by freezing fat away to the company’s line-up of aesthetic products.
FDA accepts Merck application for lung cancer combo therapy
Merck & Co on Tuesday said the FDA agreed to a speedy review of its application to combine its immunotherapy drug Keytruda with chemotherapy as an initial treatment for advanced lung cancer, potentially giving it a major leg up in the competition for the largest cancer market. Merck said the U.S. Food and Drug Read More …
France’s Ipsen to buy some Merrimack assets for up to $1 billion
French drugmaker Ipsen SA (IPN.PA) said on Monday it would buy some assets of U.S. peer Merrimack Pharmaceuticals Inc (MACK.O), including its pancreatic cancer treatment Onivyde, for up to $1 billion. Ipsen will pay $575 million at the closing of the deal and up to $450 million more, contingent on some approvals for Onivyde in Read More …
New drug approvals fall to a six-year low in 2016
Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration clearing just 22 new medicines for sale, the lowest number since 2010 and sharply down on 2015’s tally of 45.
U.S. FTC requires divestitures in $13.53 billion Boehringer-Sanofi deal
German pharmaceutical company Boehringer Ingelheim agreed to divest five types of animal health products to settle charges that a proposed asset swap with Sanofi would harm competition, the U.S. Federal Trade Commission said on Wednesday.
Senate Report on Sudden Price Hikes in Off-Patent Prescription Drugs
On the heels of headline-grabbing price spikes on prescription drugs, a bipartisan Senate report on Wednesday will call on Congress to take action to prevent huge, unjustified cost increases on decades-old prescription medicines that have no competition.
GSK launches big study to test new injection for HIV prevention
GlaxoSmithKline said on Tuesday its HIV unit ViiV Healthcare had started a large study to test an experimental long-acting injection for preventing the virus that causes AIDS.
Celgene, Versant back a biotech merger, building an antibody pipeline and lining up for the clinic
Versant Ventures and Celgene have extended their deal to foster a Toronto-based biotech called Northern Biologics, bringing in a Phase I-ready cancer drug through a merger with a small biotech in Barcelona and pumping in fresh funds to drive its pivot into the clinic.
Obama Signs Bill to Speed Medical Breakthroughs, Boost NIH Funding
President Barack Obama signed into law the 21st Century Cures Act, a sweeping health package to spur new medical treatments, reform mental health care and provide state grants to curb opioid abuse.